M.L. Martino

420 total citations
16 papers, 280 citations indexed

About

M.L. Martino is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, M.L. Martino has authored 16 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 6 papers in Genetics and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in M.L. Martino's work include Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). M.L. Martino is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). M.L. Martino collaborates with scholars based in Spain and Brazil. M.L. Martino's co-authors include D Prados, N. Rodríguez, Francisco J. Márquez‐Malaver, Isabel Montero, José Falantes, Ildefonso Espigado, Josè Antonio Pérez-Simón, Rocío Parody, P. Morales and M Rovira and has published in prestigious journals such as Blood, Haematologica and American Journal of Hematology.

In The Last Decade

M.L. Martino

16 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.L. Martino Spain 8 145 88 84 82 65 16 280
José Falantes Spain 10 198 1.4× 73 0.8× 88 1.0× 47 0.6× 44 0.7× 29 291
Sushrut Patil Australia 10 98 0.7× 81 0.9× 68 0.8× 78 1.0× 61 0.9× 35 292
Montserrat Rafel Spain 5 184 1.3× 38 0.4× 99 1.2× 36 0.4× 183 2.8× 9 293
Rebeca Rodríguez‐Veiga Spain 10 171 1.2× 36 0.4× 147 1.8× 38 0.5× 49 0.8× 39 326
R. M. Stone United States 9 189 1.3× 28 0.3× 129 1.5× 36 0.4× 60 0.9× 13 304
Elisa Cerqui Italy 9 203 1.4× 50 0.6× 91 1.1× 36 0.4× 83 1.3× 19 285
Tomofumi Yano Japan 9 40 0.3× 83 0.9× 63 0.8× 88 1.1× 19 0.3× 25 257
Michael Bär United States 8 48 0.3× 87 1.0× 54 0.6× 28 0.3× 29 0.4× 20 246
Véronique Leblond France 9 74 0.5× 88 1.0× 37 0.4× 98 1.2× 98 1.5× 21 295
Federica Lessi Italy 8 139 1.0× 65 0.7× 89 1.1× 33 0.4× 94 1.4× 30 377

Countries citing papers authored by M.L. Martino

Since Specialization
Citations

This map shows the geographic impact of M.L. Martino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.L. Martino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.L. Martino more than expected).

Fields of papers citing papers by M.L. Martino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.L. Martino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.L. Martino. The network helps show where M.L. Martino may publish in the future.

Co-authorship network of co-authors of M.L. Martino

This figure shows the co-authorship network connecting the top 25 collaborators of M.L. Martino. A scholar is included among the top collaborators of M.L. Martino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.L. Martino. M.L. Martino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Falantes, José, Francisco J. Márquez‐Malaver, Cristina Calderón‐Cabrera, et al.. (2018). Evaluation of Parameters Related to the Probability of Leukemic Progression in Patients With Lower-Risk Myelodysplastic Syndrome. Clinical Lymphoma Myeloma & Leukemia. 18(7). 469–474.e1. 2 indexed citations
2.
Falantes, José, Francisco J. Márquez‐Malaver, Cristina Calderón‐Cabrera, et al.. (2016). The incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndrome*. Leukemia & lymphoma. 58(8). 1893–1902. 7 indexed citations
3.
López‐Corral, Lucía, Luís A. Corchete, María Eugenia Sarasquete, et al.. (2014). Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies. Haematologica. 99(8). 1365–1372. 61 indexed citations
4.
Falantes, José, José I. Piruat, Francisco J. Márquez‐Malaver, et al.. (2014). Overexpression of GYS1, MIF, and MYC Is Associated With Adverse Outcome and Poor Response to Azacitidine in Myelodysplastic Syndromes and Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 15(4). 236–244. 28 indexed citations
5.
Calderón‐Cabrera, Cristina, Francisco J. Márquez‐Malaver, Rocío Parody, et al.. (2013). Improvement Over the Years of Long-Term Survival in High-Risk Lymphoma Patients Treated with Hematopoietic Stem Cell Transplantation as Consolidation or Salvage Therapy. Transplantation Proceedings. 45(10). 3665–3667. 1 indexed citations
6.
Falantes, José, Francisco J. Márquez‐Malaver, Manuela Aguilar‐Guisado, et al.. (2013). Patterns of Infection in Patients With Myelodysplastic Syndromes and Acute Myeloid Leukemia Receiving Azacitidine as Salvage Therapy. Implications for Primary Antifungal Prophylaxis. Clinical Lymphoma Myeloma & Leukemia. 14(1). 80–86. 31 indexed citations
7.
Falantes, José, Francisco J. Márquez‐Malaver, M.L. Martino, et al.. (2012). Clinical Prognostic Factors for Survival and Risk of Progression to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndromes With < 10% Marrow Blasts and Non-Unfavorable Cytogenetic Categories. Clinical Lymphoma Myeloma & Leukemia. 13(2). 144–152. 13 indexed citations
8.
López‐Corral, Lucía, Luís A. Corchete, María‐Victoria Mateos, et al.. (2012). Transcriptome Analysis Reveals Molecular Profiles Associated with Evolving Steps of Monoclonal Gammopathies.. Blood. 120(21). 2914–2914. 1 indexed citations
9.
Espigado, Ildefonso, Ana Marín‐Niebla, Eduardo Ríos, et al.. (2005). Hemopoietic Stem Cell Transplantation in Childhood: Reduction in Mortality and Improvement of Survival Over the Years. Transplantation Proceedings. 37(3). 1555–1556. 3 indexed citations
10.
Sanz-Rodrı́guez, César, Monica López‐Duarte, M. Jurado, et al.. (2004). Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections. Bone Marrow Transplantation. 34(1). 13–20. 70 indexed citations
11.
Rodríguez, N., José A. Quesada, José Luis Sánchez‐Ramos, M.L. Martino, & Diana Gosálvez Prados. (1999). [Information and worry among patients with non-oncohematological pathologies upon arrival at the hematology clinic].. PubMed. 44(5). 364–70. 1 indexed citations
12.
Rodríguez, N., et al.. (1998). rHuEpo for the treatment of anemia in myelofibrosis with myeloid metaplasia. Experience in 6 patients and meta-analytical approach.. PubMed. 83(7). 616–21. 35 indexed citations
13.
Rodríguez, N., et al.. (1998). Waldenström's macroglobulinemia complicated with acute myeloid leukemia. Report of a case and review of the literature.. PubMed. 83(1). 91–2. 12 indexed citations
14.
Rodríguez, N., et al.. (1998). [Acute myeloid leukemia in those over 70 years of age. Experience using low-dose ara-C treatment].. PubMed. 43(1). 35–9. 2 indexed citations
15.
Rodrìguez, J. N., et al.. (1997). Aleukemic leukemia cutis preceding overt acute myeloid leukemia in myelodysplastic syndrome. American Journal of Hematology. 54(1). 91–92. 9 indexed citations
16.
Jurado, A., et al.. (1992). [Chronic neutrophilic leukemia associated with myeloma. Simultaneous presentation].. PubMed. 37(5). 403–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Falantes Breakdown of academic impact, for papers by Sushrut Patil Breakdown of academic impact, for papers by Montserrat Rafel Breakdown of academic impact, for papers by Rebeca Rodríguez‐Veiga Breakdown of academic impact, for papers by R. M. Stone Breakdown of academic impact, for papers by Elisa Cerqui Breakdown of academic impact, for papers by Tomofumi Yano Breakdown of academic impact, for papers by Michael Bär Breakdown of academic impact, for papers by Véronique Leblond Breakdown of academic impact, for papers by Federica Lessi
Rankless by CCL
2026